| Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
|---|
| 12/22/2004 | CN1180873C Microfiltration using activated carbon |
| 12/21/2004 | US6833448 Annexin derivatives with endogenous chelation sites |
| 12/21/2004 | US6833245 Methods for screening for transdominant effector peptides and RNA molecules |
| 12/21/2004 | US6833132 Method of stimulating epithelial cells using keratinocyte growth factor (KGF) and method of inhibiting KGF activity |
| 12/21/2004 | CA2390358C Process for rapid solution synthesis of peptides |
| 12/16/2004 | WO2004108750A1 Process for the separation of proteins |
| 12/16/2004 | WO2004108749A2 Binding peptides: methods for their generation and use |
| 12/16/2004 | WO2004108667A2 Formation of novel erythropoietin conjugates using transglutaminase |
| 12/16/2004 | WO2004107874A1 Method for the preparation of an amino acids-containing solution and use of such a solution |
| 12/16/2004 | WO2003050245A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 12/16/2004 | US20040254347 Immobilizing tetrapeptide to solid support via exposure to transglutaminase for use as tool in enhancing immune response; immunotherapy |
| 12/16/2004 | US20040254119 Polypeptide conjugates with extended circulating half-lives |
| 12/16/2004 | US20040253687 Using multicompartment apparatus and affinity chromatography to isolate/purify preferential protein from cell solutions |
| 12/16/2004 | US20040253667 Expression vector comprising nuclelotide sequences coding membrane protein for use in identifying modulator for treatment of cell proliferative, nervous system and inflammatory diseases |
| 12/16/2004 | US20040253666 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 12/16/2004 | US20040253636 Identifying preferential protein in mixture; comprising isoelectric focusing, using carrier ampholytes and/or immobilised pH gradients, followed by size separation using polyacrylamide gel electrophoresis and confirming protein identification via mass spectrum analysis; proteomics |
| 12/16/2004 | US20040253623 Nucleic acid binding proteins |
| 12/16/2004 | US20040253247 Conjugate comprising a peptide having an engineered amino acid sequence capable of binding a plasma protein, said peptide conjugated to the therapeutic or diagnostic substance, wherein elimination half time of conjugate exceeds that of unconjugated therapeutic or diagnostic substance; peptide ligands |
| 12/16/2004 | US20040251188 Copolymeric dendrimer having a hydrophilic polyamidoamine or a hydrophilic polypropyleneimine interior and hydrophobic organosilicon exterior made by reacting a hydrophilic dendrimer having amino surface groups with an organosilicon compound |
| 12/16/2004 | CA2527665A1 Formation of novel erythropoietin conjugates using transglutaminase |
| 12/15/2004 | EP1486511A1 Refolding of polypeptides |
| 12/15/2004 | EP1485411A2 Arrays of cytosolic accessory proteins immobilized on a surface and pertinent methods |
| 12/15/2004 | EP1485407A1 A mutated immunoglobulin-binding protein |
| 12/15/2004 | EP1485406A2 Highly homogeneous molecular markers for electrophoresis |
| 12/15/2004 | EP1485139A1 Biomatrix and method for producing the same |
| 12/15/2004 | EP1414307A4 Method of enhancing the extraction of proteinase inhibitors |
| 12/15/2004 | EP0950112A4 Photolabile polymer array synthesis methods |
| 12/15/2004 | EP0773996B1 INTERRUPTION OF BINDING OF MDM2 AND p53 PROTEIN AND THERAPEUTIC APPLICATION THEREOF |
| 12/15/2004 | CN1179781C Electro ultrafiltration liquation crystallization separation purification method of biomacromolecule |
| 12/15/2004 | CN1179727C Epiderm specificity transfer factor |
| 12/14/2004 | US6831162 Protein/polypeptide-k obtained from Momordica charantia and a process for the extraction thereof |
| 12/14/2004 | US6831161 For chromatography; genetic engineering; albumin-binding protein |
| 12/14/2004 | US6831160 Method of affinity purifying proteins using modified bis-arsenical fluorescein |
| 12/14/2004 | US6831159 Method for purifying factor VIII/vWF company by cation-exchange chromatography |
| 12/14/2004 | US6831157 Process for the purification of serum albumin |
| 12/14/2004 | US6831150 Combining an aldehyde or ketone, base, the glycopeptide, acidifying the reaction mixture and combining with a reducing agent to alkylate the glycopeptide at the saccharide amine; glycopeptide antibiotics |
| 12/14/2004 | CA2180555C Radiolabeled annexins |
| 12/09/2004 | WO2004106923A1 Differential analysis of cell surface proteins on closed membrane structures by labelling with dyes in the presence of an internal standard |
| 12/09/2004 | WO2004106514A1 Method of recovering protein by deubiquitinating ubiquitinated protein |
| 12/09/2004 | WO2004106497A2 Imageable animal model of sars infection |
| 12/09/2004 | WO2004106363A2 A tag for purification of peptides |
| 12/09/2004 | WO2004106362A2 Oxidation of peptides |
| 12/09/2004 | WO2004106361A2 Peptides for metal ion affinity chromatogrpahy |
| 12/09/2004 | WO2004105685A2 Displaceable linker solid phase chemical ligation |
| 12/09/2004 | WO2004092203A3 Process for preparing macrocyclic compounds |
| 12/09/2004 | US20040249576 Methods for rational pegylation of proteins |
| 12/09/2004 | US20040249574 Markovian domain fingerprinting in statistical segmentation of protein sequences |
| 12/09/2004 | US20040249130 Aptamer-toxin molecules and methods for using same |
| 12/09/2004 | US20040249121 Providing protected linear peptide, reacting protected peptide with acidic composition to produce semi-protected linear peptide with orthogonal protecting group on thiol-containing residues, purify peptide, treat with oxidizing agent, recover cyclic peptide such as octreotide, calcitonin, oxytocin |
| 12/09/2004 | US20040248975 Complexating systems, intermediates for their production and method for obtaining and using the same |
| 12/09/2004 | US20040248817 Therapy for cardiovascular disorders; hypotensive agents; congestive heart failure |
| 12/09/2004 | US20040248779 subjecting a diene to metathesis cyclization reaction in the presence of a benzylidene ruthenium catalyst |
| 12/09/2004 | US20040248776 Intermediates and methods for making heptapeptide oxytocin analogues |
| 12/09/2004 | US20040248270 Process for producing concentrated/purified protein using clay mineral composition |
| 12/09/2004 | US20040248251 Receptors and membrane associated proteins |
| 12/09/2004 | US20040248249 Protein for use in treatment, prevention and diagnosis of cell proliferative, autoimmune/inflammatory, cardiovascular, neurological, and developmental disorders |
| 12/09/2004 | US20040248241 Compositions and methods for eliciting an immune response to Gram-negative bacterial infections |
| 12/09/2004 | US20040248212 determine the specific sequence of that portion of peptides or proteins that bind to a receptor or target of interest, or mediate a biological activity of interest; forming a metallopeptides with serially substituted sequences and screening for altered binding activity; metallopeptide libraries |
| 12/09/2004 | US20040248162 Releasable polymer arrays |
| 12/09/2004 | US20040248147 Biopolymer support for use in genomics, gene expression analysis, sequencing, DNA fingerprinting and mapping biological macromolecules |
| 12/09/2004 | US20040248143 Generating novel polypeptides via non-stochastic polynucleotide site-saturation mutagenesis; protein bioengineering |
| 12/09/2004 | US20040248127 Using polyacrylamide electrophoresis to fractionate covalently modified soluble membrane proteins in solution |
| 12/09/2004 | US20040244867 Device for silmultaneous multiple and high parallel synthesis |
| 12/09/2004 | DE10322414A1 Immobilizing proteins on polymeric film substrates, useful in preparation of diagnostic and screening arrays, where the polymer has been modified with chromatographically active functional groups |
| 12/09/2004 | CA2527795A1 Methods for synthesizing conformationally constrained peptides, peptidometics and the use thereof as synthetic vaccines |
| 12/09/2004 | CA2527674A1 A tag for purification of peptides |
| 12/09/2004 | CA2527296A1 Imageable animal model of sars infection |
| 12/09/2004 | CA2527158A1 Oxidation of peptides |
| 12/09/2004 | CA2525685A1 Differential analysis of cell surface proteins on closed membrane structures by labelling with dyes in the presence of an internal standard |
| 12/08/2004 | EP1484699A2 Protein design automation for protein libraries |
| 12/08/2004 | EP1484340A1 Antibodies to a novel mammalian protein associated with uncontrolled cell division |
| 12/08/2004 | EP1483415A2 A non-invasive diagnostic test utilizing histone modification markers |
| 12/08/2004 | EP1404428A4 Methods for purifying highly anionic proteins |
| 12/08/2004 | EP1114040B1 PROCESS FOR OBTAINING HMG-CoA REDUCTASE INHIBITORS OF HIGH PURITY |
| 12/08/2004 | EP0575432B1 Modified proteins and their use for controlling viral infections |
| 12/08/2004 | CN1553897A Dolastatin 10 derivatives |
| 12/08/2004 | CN1552737A Process for the preparation of resin-bound cyclic peptides |
| 12/08/2004 | CN1552733A Preparation of myocardium peptide |
| 12/08/2004 | CN1552732A Production of polysaccharide peptide |
| 12/08/2004 | CN1552728A Amine synthetic method |
| 12/08/2004 | CN1552726A Purification of tetramucoprotein as protein label for early dianosis of oophoroma |
| 12/08/2004 | CN1179040C Cyclic peptides |
| 12/08/2004 | CN1178905C Novel peptide derivative |
| 12/07/2004 | US6828422 Protein/(poly)peptide libraries |
| 12/07/2004 | US6828417 For measurement of analytes to be measured in samples derived from living bodies, such as body fluids (e.g. serum, blood, plasma, urine, etc.), lymphocyte, hemocyte, and various cells |
| 12/02/2004 | WO2004104548A2 Solution phase electrophoresis device, components, and methods |
| 12/02/2004 | WO2004104025A1 Method of chromatographic analysis of a protein solution |
| 12/02/2004 | WO2004104023A2 Metal chelate complexes immobilized on solid supports for peptide preparation |
| 12/02/2004 | WO2004103530A1 Process for prefiltration of a protein solution |
| 12/02/2004 | WO2004103519A2 External gradient chromatofocusing |
| 12/02/2004 | WO2004103518A1 Protein separation column |
| 12/02/2004 | WO2004103269A2 Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of the genus borrelia |
| 12/02/2004 | WO2003102020A3 Carbon nanotube binding peptides |
| 12/02/2004 | WO2003072709A3 Variant tat proteins and methods for use thereof |
| 12/02/2004 | US20040243316 Crystallographic structure of the androgen receptor ligand binding domain |
| 12/02/2004 | US20040242484 Specific polypeptides, useful as nematocides |
| 12/02/2004 | US20040242477 Capable of introducing aldehyde or ketone functions into proteins in a site-specific and pharmaceutically acceptable manner |
| 12/02/2004 | US20040242467 Contacting an aqueous solution of the lipopeptide antibiotic and a divalent metal ion with an organic solvent, thereby extracting the lipopeptide antibiotic into the organic solvent; andcontacting the organic solvent extract of the lipopeptide antibiotic with acid |
| 12/02/2004 | US20040242458 VP1 of foot-and-mouth disease virus |
| 12/02/2004 | US20040241878 Method of purifying polypeptides by simulated moving bed chromatography |